transcriptomics

Researchers scratch the surface of schizophrenia susceptibility by uncovering DNA methylation differences in neonatal blood samples.

Rare samples saved 35 years ago helped researchers map gene expression and cell differentiation in first trimester placentas.

Clinicians and researchers teamed up to investigate how inappropriate proinflammatory mechanisms contribute to the pathogenesis of drug-refractory epilepsy.

An in situ map of copy number variations in prostate tissue reveals that purportedly cancerous genomic changes frequently occur in the healthy tissue surrounding tumors.

There is only one week remaining to submit your new product to vie for a coveted spot in The Scientist’s 2022 competition.

A new CRISPR screening technology allows scientists to recreate tumor heterogeneity in vivo and study how it affects all aspects of cancer biology.

A novel atlas reveals region-specific links between structural, mechanical, and genetic properties within the heart.

Human data and experiments in mice challenge the common use of anti-inflammatory drugs to treat pain.

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.

Genetic, transcriptomic, and epigenetic data reveal molecular mechanisms tying these disorders to each other and to immune disfunction.

Genes associated with preterm birth and protecting the fetus from the mother’s immune system appear to be regulated by HAND2.

The presence of a particular set of RNAs in the blood forewarns of an onset of severe symptoms and points to the cells involved.

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.